(Q30838132)

19 October 2017

Audiologic monitoring of multi-drug resistant tuberculosis patients on aminoglycoside treatment with long term follow-up (English)

1 reference

19 October 2017

multiple drug resistance

0 references

tuberculosis

0 references

author name string

Prahlad Duggal

series ordinal

1

1 reference

19 October 2017

Malay Sarkar

series ordinal

2

1 reference

19 October 2017

12 November 2007

1 reference

BMC Ear, Nose and Throat Disorders

19 October 2017

1 reference

19 October 2017

7

1 reference

19 October 2017

5

1 reference

https://scigraph.springernature.com/pub.10.1186/1472-6815-7-5

19 October 2017

0 references

cites work

Auditory monitoring in ototoxicity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Aminoglycoside-induced ototoxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Multidrug-resistant tuberculosis: a menace that threatens to destabilize tuberculosis control

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Multidrug-resistant tuberculosis (MDR-TB): epidemiology, prevention and treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Aminoglycoside nephrotoxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

The global situation of MDR-TB.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Current medical treatment for tuberculosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

The diagnosis and management of multiple-drug-resistant-tuberculosis at the beginning of the new millenium

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Occurrence of serious adverse effects in patients receiving community-based therapy for multidrug-resistant tuberculosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Capability of serum to convert streptomycin to cytotoxin in patients with aminoglycoside-induced hearing loss

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Prospective evaluation of the effect of an aminoglycoside dosing regimen on rates of observed nephrotoxicity and ototoxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

A meta-analysis of extended-interval dosing versus multiple daily dosing of aminoglycosides.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Frequency and type of reactions to antituberculosis drugs: observations in routine treatment

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

A meta-analysis of studies on the safety and efficacy of aminoglycosides given either once daily or as divided doses

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Once-daily aminoglycoside dosing in immunocompetent adults: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Single or multiple daily doses of aminoglycosides: a meta-analysis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Aminoglycoside dosing considerations in intensive care unit patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Aminoglycoside cochlear ototoxicity

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Pharmacology of the antimycobacterial drugs.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Aminoglycosides: single or multiple daily dosing? A meta-analysis on efficacy and safety.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Treatment with capreomycin, with special reference to toxic effects

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Clinical response to aminoglycoside therapy: importance of the ratio of peak concentration to minimal inhibitory concentration

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Comparative study of ototoxicity and nephrotoxicity in patients randomly assigned to treatment with amikacin or gentamicin.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Human cochlear pathology in aminoglycoside ototoxicity--a review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Determinants of efficacy and toxicity of aminoglycosides

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Aminoglycoside-induced hearing loss in humans

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Influence of dosage schedule on renal cortical accumulation of amikacin and tobramycin in man

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Prevalences of Pneumocystis jiroveci, Mycobacterium tuberculosis and Streptococcus pneumoniae infection in children with severe pneumonia, in a tertiary referral hospital in northern Tanzania

21 June 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-7-5

Detection of aminoglycoside ototoxicity by high-frequency auditory evaluation: selected case studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-7-5

Prevention of noise- and drug-induced hearing loss with D-methionine

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-7-5

A meta-analysis of the relative efficacy and toxicity of single daily dosing versus multiple daily dosing of aminoglycosides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1186%2F1472-6815-7-5

WITHDRAWN: Interventions for promoting adherence to tuberculosis management

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Adverse events in the treatment of multidrug-resistant tuberculosis: results from the DOTS-Plus initiative.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

Hearing loss and nephrotoxicity in long-term aminoglycoside treatment in patients with tuberculosis.

25 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2204030

25 November 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/17997841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Once-daily dosing decreases renal accumulation of gentamicin and netilmicin

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17997841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Aminoglycoside therapy. Improving patient response and safety

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/17997841

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1186/1472-6815-7-5

1 reference

Dimensions Publication ID

19 October 2017

0 references

1 reference

19 October 2017

PubMed publication ID

17997841

1 reference